Saturday 3rd May 2025

In this Managing for Profit, a biological report partnership with Terrasym, Chief Commercial Officer for NewLeaf Symbiotics Matt Helms reviews his transition from “big ag” to a start-up company. He gives an outlook for the future of start-ups like NewLeaf Symbiotics and highlights innovative products under the Terrasym brand coming in 2022 and beyond.

   

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*